US Broker Ratings

McKesson Corporation (MCK) Stock Analysis: Analyst Ratings Signal 30% Upside Potential for Healthcare Giant

For investors looking to strengthen their portfolios with a robust player in the healthcare sector, McKesson Corporation (NYSE: MCK) presents a compelling opportunity. With its extensive operations in medical distribution..

ResMed Inc. (RMD) Stock Analysis: A Leading Healthcare Player with 30% Upside Potential

ResMed Inc. (NYSE: RMD), a prominent figure in the healthcare sector, continues to cement its position as a key player in the medical instruments and supplies industry. With a market..

Chemed Corp (CHE) Stock Analysis: Navigating the Healthcare Sector with a 5.24% Potential Upside

Chemed Corporation (NYSE: CHE), a key player in the healthcare sector, operates on two fronts through its VITAS and Roto-Rooter segments. While VITAS provides essential hospice and palliative care services,..

Align Technology, Inc. (ALGN) Stock Analysis: Unlocking 23.87% Potential Upside with a Strong Buy Consensus

Align Technology, Inc. (NASDAQ: ALGN) stands out in the healthcare sector as a key player in the medical instruments and supplies industry. Known for its innovative Invisalign clear aligners and..

Hologic, Inc. (HOLX) Stock Analysis: Steady Growth with Limited Upside Potential

Hologic, Inc. (NASDAQ: HOLX), a major player in the healthcare sector, stands out in the medical instruments and supplies industry with a robust market capitalization of $16.97 billion. As a..

Koninklijke Philips N.V. (PHG) Stock Analysis: Assessing a 24% Upside Potential in the Healthcare Sector

As an established player in the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) presents intriguing opportunities for investors navigating the medical devices industry. With its headquarters in Amsterdam, the Netherlands,..

Avantor, Inc. (AVTR) Stock Analysis: Evaluating Growth Potential Amidst a 19.41% Upside

Avantor, Inc. (AVTR), a key player in the healthcare sector, stands out as an intriguing investment opportunity in the medical instruments and supplies industry. With a market capitalization of $5.67..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a 21.08% Potential Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN) is a prominent player in the healthcare sector, specifically within the medical devices industry. Headquartered in Watford, United Kingdom, this venerable company, founded..

Fresenius Medical Care AG (FMS) Stock Analysis: Assessing a 24.54% Potential Upside for Investors

Fresenius Medical Care AG (NYSE: FMS), headquartered in Bad Homburg, Germany, stands as a prominent player in the healthcare sector, specifically in the medical care facilities industry. With a market..

GE HealthCare Technologies (GEHC) Stock Analysis: Uncovering a 25.96% Potential Upside

As GE HealthCare Technologies Inc. (NYSE: GEHC) navigates the dynamic landscape of the healthcare sector, investors are keeping a close watch on the company’s stock performance and growth potential. With..

Novo Nordisk A/S (NVO) Stock Analysis: Unveiling Growth Potential with a 3.91% Dividend Yield

Novo Nordisk A/S (NVO), a titan in the healthcare sector, is widely recognized as a formidable player in the global pharmaceutical landscape. With its headquarters in Bagsvaerd, Denmark, the company..

BioNTech SE (BNTX) Stock Analysis: Exploring a 37.9% Potential Upside Amidst Biotech Challenges

BioNTech SE (NASDAQ: BNTX) has made headlines as a frontrunner in biotechnology, notably with its mRNA vaccine for COVID-19. However, beyond the past successes, investors are now keen to understand..

Tenet Healthcare Corporation (THC) Stock Analysis: Exploring a 28.97% Potential Upside

Tenet Healthcare Corporation (NYSE: THC) presents a compelling case for investors seeking exposure in the healthcare sector, particularly in the medical care facilities industry. With a market capitalization of $16.4..

Exelixis, Inc. (EXEL) Stock Analysis: Strong Revenue Growth and Promising Pipeline Drive Investor Interest

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology industry, is attracting attention in the healthcare sector due to its robust revenue growth and an impressive product pipeline aimed..

Incyte Corporation (INCY): Investor Outlook with a Promising 10% Upside Potential

Incyte Corporation (NASDAQ: INCY) stands out as a compelling investment opportunity in the biopharmaceutical sector, particularly for investors eyeing potential growth in the healthcare industry. With a market capitalization of..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: A Deep Dive into Valuation Insights and Growth Potential

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) continues to position itself as a formidable player in the global healthcare sector. With a market capitalization of $11.05 billion, Dr. Reddy’s operates predominantly..

Cigna Group (CI) Stock Analysis: Potential Upside and Analyst Consensus Signal Promising Growth

The Cigna Group (NYSE: CI), a titan in the healthcare plans industry, presents an intriguing opportunity for investors seeking exposure to a robust sector. With its roots dating back to..

GSK plc (GSK) Stock Analysis: Evaluating a 14.37% Upside Potential in the Healthcare Sector

Investors seeking opportunities in the healthcare sector may find GSK plc (NYSE: GSK) an intriguing proposition. As a stalwart in the global pharmaceutical landscape, GSK’s extensive portfolio in vaccines and..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Exploring a 25% Upside Potential with Robust Revenue Growth

Investors looking to capitalize on burgeoning opportunities in the healthcare sector may want to keep a close eye on Neurocrine Biosciences, Inc. (NBIX). With a market capitalization of $15.31 billion,..

Danaher Corporation (DHR) Stock Analysis: Potential 46% Upside Amid Strong Buy Ratings

Danaher Corporation (NYSE: DHR) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $121.14 billion, Danaher operates a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds